Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
University of Colorado, Denver
M.D. Anderson Cancer Center
Hackensack Meridian Health
Hackensack Meridian Health
Geneve TEAM Ambulances
H. Lee Moffitt Cancer Center and Research Institute
University of Nebraska
University of Rochester
University of Rochester
Medical College of Wisconsin
City of Hope Medical Center
Wake Forest University Health Sciences
Dana-Farber Cancer Institute
Thomas Jefferson University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Chicago
University of Miami
University of Nebraska
University of California, Irvine
University of Washington
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Penn State University
Dana-Farber Cancer Institute
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Iowa
Ohio State University Comprehensive Cancer Center
Medical College of Wisconsin
University of Colorado, Denver
Children's Hospital of Philadelphia
Masonic Cancer Center, University of Minnesota